Diana McKenzie insider trades

Open-market stock purchases and sales by Diana McKenzie, Director at Metlife Inc, from SEC Form 4 filings since Nov 1, 2018.

Recent trades

DateStockTradeValue
Sep 8, 2026MET Metlife IncBought (not open market)$15K
Jun 16, 2026MET Metlife IncBought (not open market)$51.3K
Jun 9, 2026MET Metlife IncBought (not open market)$14.5K
Jun 2, 2026AGL agilon health, IncBought (not open market)—
May 1, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
May 1, 2026VRTX Vertex Pharmaceuticals Inc / MASold (not open market)—
May 1, 2026VRTX Vertex Pharmaceuticals Inc / MABought (not open market)—
Apr 1, 2026MET Metlife IncBought (not open market)$51.3K
Mar 10, 2026MET Metlife IncBought (not open market)$13.3K
Jan 2, 2026MET Metlife IncBought (not open market)$51.3K
Dec 9, 2025MET Metlife IncBought (not open market)$12.9K

Companies traded

  • MET Metlife Inc: other filings, last Sep 8, 2026
  • AGL agilon health, Inc: 2 buys, last Jun 2, 2026
  • VRTX Vertex Pharmaceuticals Inc / MA: other filings, last May 1, 2026
  • CHNG Change HealthCare Inc: other filings, last Oct 3, 2022

Get free alerts when Diana McKenzie files a new trade →